Cardiovascular comorbidities of type 2 diabetes mellitus: Defining the potential of glucagonlike peptide1-based therapies

Medicine and Dentistry

• Maturity Onset Diabetes of the Young 100%
• Cardiovascular Disease 83%
• Glucagon 83%
• Receptor 50%
• Cardiovascular System 50%
• Obesity 50%
• Agonist 50%
• Therapeutic Procedure 50%
• Morbidity 33%
• Epidemic 33%
• Fatty Acid 33%
• Combination Therapy 33%
• Mortality 33%
• Marker 33%
• Prevalence 16%
• Hyperglycemia 16%
• In Vitro 16%
• Pathogenesis 16%
• Upregulation 16%
• Blood Pressure 16%
• Diabetes Mellitus 16%
• Cardiovascular Risk 16%
• Dyslipidemia 16%
• Vasculitis 16%
• Cardiovascular Imaging 16%
• Incretin 16%
• Water-Electrolyte Imbalance 16%
• C Reactive Protein 16%
• Endothelial Dysfunction 16%
• Sedentary Lifestyle 16%
• Plasminogen Activator 16%
• Brain Natriuretic Peptide 16%
• Postmortem Imaging 16%
• Motivation 16%
• Pathology 16%
• Observation 16%
• Incidence 16%
• Reactive Oxygen Species 16%
• Inpatient 16%
• Human 16%
• Comorbidity 16%
• Atherosclerosis 16%